Antidepressant Pharmacotherapy: Economic Evaluation of Fluoxetine, Paroxetine and Sertraline in a Health Maintenance Organization
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The present study was designed to compare direct health service expenditures, for the treatment of depression, among patients enrolled in a health maintenance organization, and prescribed one of three selective serotonin reuptake inhibitors, fluoxetine, paroxetine or sertraline. Information regarding depression-related health service use was derived from the computer archive of a network-model health maintenance organization system serving 700 000 beneficiaries. A total of 744 health maintenance organization beneficiaries were found to satisfy the study selection criteria. Multivariate regression analysis was used to determine the incremental influence of selected demographic, clinical, financial and provider characteristics on health service expenditures related to the treatment of depression (ICD-9-CM, or DSM-IV code 296.2) 1 year after the start of antidepressant pharmacotherapy. Multivariate findings indicate that treatment with paroxetine increases average expenditures for physician visits ($31.93; P ≤ 0.05), psychiatric visits ($19.33; NS), laboratory tests ($2.35; P ≤ 0.05), hospitalizations ($85.33; P ≤ 0.05), psychiatric hospitalizations ($82.01; P ≤ 0.05), and antidepressant pharmacotherapy ($63.72; P ≤ 0.05), for a total per capita increase in health service use of $284.68 ( P ≤ 0.05), compared with treatment with fluoxetine. Sertraline treatment increases average expenditures for physician visits ($21.74; P ≤ 0.05), psychiatric visits ($56.79; P ≤ 0.05), laboratory tests ($1.21; P ≤ 0.05), hospitalizations ($70.59; P ≤ 0.05), psychiatric hospitalizations ($95.75; P ≤ 0.05), and antidepressant pharmacotherapy ($69.85; P ≤ 0.05), for a total per capita increase in health service use of $315.96 ( P ≤ 0.05), compared with treatment with fluoxetine. Economic comparisons between paroxetine and sertraline did not demonstrate any significant differences in expenditures for the health services examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485
Service utilization and social morbidity associated with depressive symptoms in the community
Johnson, J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480110054033 · Cited by 726
Health care costs associated with depressive and anxiety disorders in primary care
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.352 · Cited by 555
Collaborative Management to Achieve Treatment Guidelines: Impact on Depression in Primary Care
Katon, W. (1995) · JAMA · doi:10.1001/jama.1995.03520370068039 · Cited by 6
Cited by
Kulin, N. A., Pastuszak, A., Sage, S. R., Schick-Boschetto, B., Spivey, G., Feldkamp, M., Ormond, K., Matsui, D., Stein-Schechman, A. K., Cook, L., et al. (1998) · JAMA · doi:10.1001/jama.279.8.609 · Cited by 424
Goldstein, B. J., & Goodnick, P. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003041 · Cited by 171
Selective Serotonin Reuptake Inhibitor Usage Patterns as Risk Factors for Hospitalization
Sheffield, R. E., Sasso, A. T. L., Young, C. H., & Way, K. (2002) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1023/a:1022533118031 · Cited by 11
Cost‐effectiveness of SSRIs: a European perspective
Stewart, A. (1998) · The Journal of Mental Health Policy and Economics · doi:10.1002/(sici)1099-176x(199803)1:1<41::aid-mhp1>3.0.co;2-# · Cited by 4
(2000) · doi:10.1002/1520-6394(2000)12:1+<2::aid-da2>3.0.co;2-4
Metadata
- Authors
- Sclar, D. A., Robison, L. M., Skaer, T. L., Galin, R. S., Legg, R. F., Nemec, N. L., Hughes, T. E., Buesching, D. P., & Morgan, M.
- Venue
- Journal of International Medical Research
- Publisher
- SAGE Publications
- Published
- 1995-11
- Volume
- 23
- Issue
- 6
- Pages
- 395-412
- ISSN
- 0300-0605 (ISSN-L)
- 1473-2300
- OpenAlex
- W2095901534
- Cited by
- 82
- References
- 4
- FWCI
- 30.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.